The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Most pharmas have been so undervalued , it's took covid to catch them up a bit .The potential and need for some of these companies is massive. It's got to be better than sticking your money in oil or retail.
I disagree it’s being pumped, there’s not a huge swathe of Covid investors on this board and the SP isn’t have wild fluctuations. It’s been a steady rise. Of course there has been little news to substantiate that, which is why I’ve sold chunks on the way up but I don’t hold your pessimism. I think it’s very much a wait and see from here
Thing is BUTD it's not like you've been a little bit wrong with this share, you've been several hundred percent wrong. Coming back with the same arguments on a down day isn't going to change that..
BUTD I see your here again trying to lower the sp . Looking to come back here myself but please if I do , will you go away lol
Noting your 5 exclaimation marks. You really care.
AGM on the morrow.
Also.......
Positive progress made on commercial research collaboration deal with Novo Nordisk announced in the prior year
· Secured a further deal with a top five Global biopharma company in a specific area of neurodegeneration
· Business development activities continue with a number of discussions progressing on a range of revenue-generating and value-creating deals
Great for trading? Hardly .. it's been a pretty much one way bet since you last said it was all hype at 7p...
Why you on about a placing, sufficient funding for next two year.
Our latest budget, updated following the post year-end injection of cash, shows that we have sufficient funds to continue our operations for at least the next two financial years. This budget includes prudent revenue assumptions, although we are in late stage discussions regarding a number of exciting potential collaborations and we are looking forward to working closely with business development opportunities in defining how we could help partners better understand their chosen area of biology.
You're right of course - never fall in love with a share. Like politicians they invariably disappoint.
Your posting hx - and I remember you well - shows someone willing to go toe to toe with the negative poster we haven't seen too much of lately. You wanted facts, not speculation. You cut people down when they started fretting about cash-burn. You put them straight, based on fact.
Very wise.
Up to you Reno just check my history on ETX alone.. therapeutics R&D takes time and money... will check in every couple of months... don't be fooled by the rise, research, step back, look again and do your research on therapeutics companies so that the space is understood. Is Ali going to raise more money soon, hmm check his history... GLA - always have a 360 view not an emotional one when investing.
https://www.nature.com/articles/s41591-019-0580-6
General paper on RNA therapeutics.
The one below gives a good overview of the playing field at the moment.
https://www.nature.com/articles/d41573-020-00078-0
It's an accelerating field, Covid-19 related and shows real appetite from ETX in getting involved. It show integrity - I would argue the direct opposite of the flash-in-the-pan insinuation from the last poster.
Other insinuations about Ali Mortazavi - let's hear them, where do we need to look? Otherwise I'm not seeing much substance in your post.
Aligator take some profits... I was in ETX for about 3 years sold up at 6p with decent profit when the cowboy Ali arrived on the scene.. do some research.... go back and look at the RNS for the past 3 years... it's your investment so the research will help inform you of your investment..
I transferred my profits into other CV stocks.. missed out on the gains here obviously but do some research and ask what is the company actually doing in CV and could this go up in smoke and back to a true evaluation some morning..
There's a 1 million marked as a sell on mine but then a 1,458,749 marked as a buy. Plenty of 250k prints as well - interesting day.
Feels like the lid is being kept on here. Lots of buys reported as sells, reported late or still not reported from earlier in the week.
Another good day in the unfolding story.
I think the reason it's attracting a lot of new money is because they aren't tied into a specific drug development, they are kind of selling shovels to the gold miners as it were. Yes it can still be a flop but at least it's not all dependent on the next clinical trial
Boom and bust has been the way of drug development previously - promising candidates brought through phases 1-3 only to 'devon loch' at the last.
ETX aims to fundamentally chane that. A comprehensive understanding of intracellular pathways and their Messenger protein systems. And today they widen their search area to RNA - imagine the possibilities! Ali talked recently about the failure of substantive treatments in hypertension, diabetes. What if this opens the gateway to epigenetic interventions at minimising the negative effects Lifestyle can have on - amongst other things - HT and DM?
(Just had some strong coffee, feeling a bit giddy)
I suspect most shareholders in ETX have limited or no knowledge of the therapeutics/pharmaceutical industry, specifically in relation to research and testing, etc. I am certainly in that league. However, I bought in here on the back of a little reading/investigation about the company, a thought that its work could/would become more valuable within the current pandemic and a relative whim. I have managed to achieve an average price of 3.2p and am now looking at over 7x growth within 8 weeks or so. Certainly one of my better investments in the last 6 months!
What intrigues me is that the sp has risen to this level on the back of what can only be described as limited achievement so far. However, the company certainly appears to be moving in the right direction in terms of research /testing partners and specialist appointments as with the latest RNS. The thrilling aspect of this industry is that it should not only attract the attention of the major investment houses in due course but, given its global potential and the covid19 situation, could also become of considerable interest to governments and international agencies with their almost inexhaustible funding.
I guess it is impossible, based on current knowledge, to predict where the sp goes from here. However, should the company discover the holy grail one could expect to see even further stellar growth, with the sp moving into the £s and so on. That said, I think we all know that it could also blow out - but that is the boom/bust risk in such investments.
All my own thoughts.